|
Volumn 24, Issue 17, 2014, Pages 4271-4275
|
Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists
|
Author keywords
Agonist; Bioisostere; Malonamide; Pyrimidine; TGR5
|
Indexed keywords
CYCLOPROPYLMALONAMIDE DERIVATIVE;
CYTOCHROME P450 1A2;
CYTOCHROME P450 2C19;
CYTOCHROME P450 2C9;
CYTOCHROME P450 2D6;
CYTOCHROME P450 3A4;
G PROTEIN COUPLED RECEPTOR;
PYRIMIDINE DERIVATIVE;
TAKEDA G PROTEIN COUPLED RECEPTOR 5;
TAKEDA G PROTEIN COUPLED RECEPTOR 5 AGONIST;
UNCLASSIFIED DRUG;
CYTOCHROME P450;
CYTOCHROME P450 INHIBITOR;
GPBAR1 PROTEIN, HUMAN;
MALONAMIDE;
MALONIC ACID DERIVATIVE;
PYRIMIDINE;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG DISTRIBUTION;
DRUG HALF LIFE;
DRUG HYDROLYSIS;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IC 50;
MALE;
MAXIMUM PLASMA CONCENTRATION;
MEAN RESIDENCE TIME;
MOUSE;
NONHUMAN;
SUBSTITUTION REACTION;
TIME TO MAXIMUM PLASMA CONCENTRATION;
AGONISTS;
ANIMAL;
BIOAVAILABILITY;
CHEMICAL STRUCTURE;
CHEMISTRY;
DOSE RESPONSE;
DRUG DEVELOPMENT;
DRUG EFFECTS;
ENZYMOLOGY;
HEK293 CELL LINE;
INSTITUTE FOR CANCER RESEARCH MOUSE;
LIVER MICROSOME;
METABOLISM;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
BIOLOGICAL AVAILABILITY;
CYTOCHROME P-450 ENZYME INHIBITORS;
CYTOCHROME P-450 ENZYME SYSTEM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DISCOVERY;
HEK293 CELLS;
HUMANS;
MALONATES;
MICE;
MICE, INBRED ICR;
MICROSOMES, LIVER;
MOLECULAR STRUCTURE;
PYRIMIDINES;
RECEPTORS, G-PROTEIN-COUPLED;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84906933589
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2014.07.026 Document Type: Article |
Times cited : (11)
|
References (14)
|